Compare AbCellera Biologics Inc (ABCL) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Standard Lithium Ltd — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: AbCellera Biologics Inc is far larger — about 4.9× Standard Lithium Ltd's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| ABCL | SLI | |
|---|---|---|
Market Cap | $2.99B | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $5.65 |
52-Week Low | $2.78 | $1.93 |
Enterprise Value | $2.58B | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
